[Skip to Navigation]
November 1966


Author Affiliations

Professor, Division of Ophthalmology Downstate Medical Center 450 Clarkson Ave Brooklyn, NY 11203

Arch Ophthalmol. 1966;76(5):764. doi:10.1001/archopht.1966.03850010766024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:  I read with considerable interest Dr. Michael Hogan's remarks concerning possible deleterious effects of α-chymotrypsin.It might have been more to the point had Dr. Hogan edited the commercial query to read, "Alpha si ? o Alpha no ?". However, since Dr. Joaquin Barraquer is equally fluent in French I am sure that only deGaulle would be upset.I agree with Dr. Hogan that it is time for a scientific reevaluation of the long-term effect of α-chymotrypsin. We should cease to condemn zonulolysis out of hand as a cause of complications which may be only coincidental. Certainly, enough evidence of directly related problems has been accumulated to warrant a full-scale investigation.In assessing our results, however, we must not lose sight of the fact that α-chymotrypsin has contributed more to cataract surgery than the lysis of the zonule. It has served to stimulate interest and enthusiasm in the cataract

First Page Preview View Large
First page PDF preview
First page PDF preview
Add or change institution